WHAT EYE PROBLEMS CAN LASER THERAPY BE APPLIED TO?

Reading time is 2 mins

.
.
EYE PROBLEMS LASER THERAPY CAN BE APPLIED TO

Refractive defects, that is, the need for glasses, is one of the health problems that cause difficulties in everyday life. These defects adversely affect the comfort of people and require the use of glasses or contact lenses to achieve good vision, and many people do not want to wear glasses in terms of external appearance. Today, with the development of medical technology, it has become possible to treat patients’ refractive errors with the help of appropriate laser applications and eliminate the need to wear glasses.

Although laser applications used in refractive surgery can be used to treat various degrees of myopia, hyperopia or astigmatism and other visual disorders, the same technology can also be used to treat some problems with the transparent layer of the eye.

Antalya laser eye therapy is a safe method of treating refractive defects such as myopia, hyperopia and astigmatism. Also, laser therapy can eliminate spots and scars on the outermost transparent layer of the eye (cornea). In some strabismus that can be treated with glasses, laser therapy can be used to treat or relieve strabismus.

.
IT IS OFTEN PREFERRED IN PEOPLE AGED 20 YEARS AND OVER

A specialist in his field will thoroughly evaluate the patient’s eye defects, the degree of the defect, the patient’s age, eye structure and other environmental factors, and after a detailed examination, he will decide which laser treatment method is preferable. In order for laser therapy to be performed, the patient must have characteristics suitable for the operation. it can be preferred for patients over the age of 20 and whose eyes have not progressed above 0.50 in the last 6 months – 1 year.

.
HOW IS THE IMPLEMENTATION PROCESS PROGRESSING?

Patients who use contact lenses should stop using lenses 1 week before eye surgery in Antalya. With the detailed measurements made in this way, the correct correction amount is determined, if necessary, the patient is called after a few days and the measurements are repeated and the first values found are verified. When the day of the operation arrives, anesthesia is applied before the procedure begins. The anesthesia method used in laser eye treatment applications is drip anesthesia. The outermost cornea of the eye is anesthetized using this anesthesia technique. Just a few drops of anesthetic are enough to numb the area. The patient will not feel any pain or soreness during the operation after the drop. This short-term operation can be completed in just five to ten minutes for each eye.

After surgery, patients usually do not need to stay in the hospital. After a detailed examination by a Turkish eye doctor, patients who have been followed up for a while can be sent home comfortably without closing their eyes.

.
LASER-TREATED EYES MAY ALSO DEVELOP DEFECTS IN THE FUTURE

If laser therapy is applied to people over the age of 20 and whose eye progression has stopped, the likelihood of developing defects again in the future is very low. The probability of recurrence of laser-treated hyperopia is much less likely than with myopia. Similarly, the biggest reason why laser eye treatment is not recommended for people under the age of 18 is that progress continues and the numbers are much more likely to re-occur than adults.

.
WHO ARE THE PEOPLE WHO ARE NOT SUITABLE FOR LASER TREATMENT?

• Those who have eye dryness problems,

• People with disfigurement of the cornea,

• Those who actively have an eye infection,

• People with a thin cornea,

Glaucoma and rheumatology patients, people with diabetes mellitus.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me